Role of Caelyx in second line treatment of ovarian cancer
The authors published their own experiences and results of Caelyx treatment based on 40 ovarian cancer patients treated in 9 different institutions. Patients had been treated with platinum based or platinum-taxol combination chemoterapy. Their average age was 57.2 years (35-80). The average time to...
Saved in:
Published in | Magyar onkologia Vol. 48; no. 1; p. 97 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | Hungarian |
Published |
Hungary
2004
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Summary: | The authors published their own experiences and results of Caelyx treatment based on 40 ovarian cancer patients treated in 9 different institutions. Patients had been treated with platinum based or platinum-taxol combination chemoterapy. Their average age was 57.2 years (35-80). The average time to progression was 3.8 months (1-8). The effects of the therapy were assessed on 36 patients and the results were 3 CR, 8 PR, 7 SD and 18 PD. Summarised the Caelyx therapy caused improvement in 30.55% of the patients and stabilisation in 19.44%. Supportive therapy was needed in 8 cases. |
---|---|
ISSN: | 0025-0244 |